Goodpasture syndrome epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 9: | Line 9: | ||
The prevalence of Goodpasture syndrome worldwide affects an estimated 1 per million persons. | The prevalence of Goodpasture syndrome worldwide affects an estimated 1 per million persons. | ||
===Incidence=== | ===Incidence=== | ||
The incidence of Goodpasture syndrome is around 1 per 2 million persons per year.<ref name="pmid10541306">{{cite journal| author=Kluth DC, Rees AJ| title=Anti-glomerular basement membrane disease. | journal=J Am Soc Nephrol | year= 1999 | volume= 10 | issue= 11 | pages= 2446-53 | pmid=10541306 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10541306 }} </ref> | The incidence of Goodpasture syndrome is around 1 per 2 million persons per year.<ref name="pmid10541306">{{cite journal| author=Kluth DC, Rees AJ| title=Anti-glomerular basement membrane disease. | journal=J Am Soc Nephrol | year= 1999 | volume= 10 | issue= 11 | pages= 2446-53 | pmid=10541306 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10541306 }} </ref> The annual incidence of Goodpasture syndrome in Europe is estimated to range from 0.5 to 1 per 1 million persons.<ref name="pmid16894954">{{cite journal| author=Fomegné G, Dratwa M, Wens R, Mesquita M, Van der Straaten M, Vanden Haute K et al.| title=[Goodpasture disease]. | journal=Rev Med Brux | year= 2006 | volume= 27 | issue= 3 | pages= 162-6 | pmid=16894954 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16894954 }}</ref> | ||
===Age=== | ===Age=== | ||
Revision as of 18:17, 4 November 2016
|
Goodpasture syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Goodpasture syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Goodpasture syndrome epidemiology and demographics |
|
Goodpasture syndrome epidemiology and demographics in the news |
|
Risk calculators and risk factors for Goodpasture syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The prevalence of Goodpasture syndrome worldwide affects an estimated 1 per million persons, with high prevalence in Caucasians. The peak incidence of the disease occurs between the ages of 20 and 30 and again at 60 and 70. [1]
Epidemiology
Prevalence
The prevalence of Goodpasture syndrome worldwide affects an estimated 1 per million persons.
Incidence
The incidence of Goodpasture syndrome is around 1 per 2 million persons per year.[2] The annual incidence of Goodpasture syndrome in Europe is estimated to range from 0.5 to 1 per 1 million persons.[3]
Age
The age at which Goodpasture syndrome occurs in two peaks 1) ages 20 and 30 2) ages 60 and 70.[1]
Gender
Males are at higher risk of developing Goodpasture syndrome at a younger age while females are at higher risk later in life.[1]
Race
In European populations between half and one case presents per million people per year. It is rarer than this in non-European populations.
References
- ↑ 1.0 1.1 1.2 Cui Z, Zhao MH (2011). "Advances in human antiglomerular basement membrane disease". Nat Rev Nephrol. 7 (12): 697–705. doi:10.1038/nrneph.2011.89. PMID 21769105.
- ↑ Kluth DC, Rees AJ (1999). "Anti-glomerular basement membrane disease". J Am Soc Nephrol. 10 (11): 2446–53. PMID 10541306.
- ↑ Fomegné G, Dratwa M, Wens R, Mesquita M, Van der Straaten M, Vanden Haute K; et al. (2006). "[Goodpasture disease]". Rev Med Brux. 27 (3): 162–6. PMID 16894954.